Paper40201829
The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model.
Titisari N and 4 others. Open Vet J, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model. Papers, record 40201829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40201829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The mechanism underlying streptozotocin injection for the development of a nontransgenic Alzheimer's disease animal model.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Streptozocin | Major topic |
| Disease Models, Animal | Major topic |
| Diabetes Mellitus, Experimental | Major topic |
| Animals | |
| Amyloid beta-Peptides | |
| Humans | |
| Blood Glucose |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28315336 | Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28315336 | PubMed |
| 2 | 28455089 | A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies. | Trends Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28455089 | PubMed |
| 3 | 18218341 | Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. | Trends Mol Med | 2008 | https://conductscience.org/library/papers/18218341 | PubMed |
| 4 | 28713158 | Amyloid beta: structure, biology and structure-based therapeutic development. | Acta Pharmacol Sin | 2017 | https://conductscience.org/library/papers/28713158 | PubMed |
| 5 | 24931034 | Insulin action in brain regulates systemic metabolism and brain function. | Diabetes | 2014 | https://conductscience.org/library/papers/24931034 | PubMed |
| 6 | 27913964 | Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice. | Neurotox Res | 2017 | https://conductscience.org/library/papers/27913964 | PubMed |
| 7 | 27771511 | High fat diet induces brain insulin resistance and cognitive impairment in mice. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/27771511 | PubMed |
| 8 | 22423571 | Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice. | Proc West Pharmacol Soc | 2011 | https://conductscience.org/library/papers/22423571 | PubMed |
| 9 | 25744568 | Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism. | Mol Neurobiol | 2016 | https://conductscience.org/library/papers/25744568 | PubMed |
| 10 | 19605645 | Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. | J Neurosci | 2009 | https://conductscience.org/library/papers/19605645 | PubMed |
| 11 | 30186480 | Effect of intraperitoneal or intracerebroventricular injection of streptozotocin on learning and memory in mice. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/30186480 | PubMed |
| 12 | 21519521 | A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models. | J Clin Neurol | 2011 | https://conductscience.org/library/papers/21519521 | PubMed |
| 13 | 22886150 | What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. | J Neural Transm (Vienna) | 2013 | https://conductscience.org/library/papers/22886150 | PubMed |
| 14 | 10322503 | Poly (ADP-ribose) polymerase, nitric oxide and cell death. | Trends Pharmacol Sci | 1999 | https://conductscience.org/library/papers/10322503 | PubMed |
| 15 | 34943213 | Mangostanaxanthone IV Ameliorates Streptozotocin-Induced Neuro-Inflammation, Amyloid Deposition, and Tau Hyperphosphorylation via Modulating PI3K/Akt/GSK-3β Pathway. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34943213 | PubMed |
| 16 | 34283253 | Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice. | Exp Brain Res | 2021 | https://conductscience.org/library/papers/34283253 | PubMed |
| 17 | 22229116 | Neuropathological alterations in Alzheimer disease. | Cold Spring Harb Perspect Med | 2011 | https://conductscience.org/library/papers/22229116 | PubMed |
| 18 | 16627931 | Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. | J Alzheimers Dis | 2006 | https://conductscience.org/library/papers/16627931 | PubMed |
| 19 | 10818091 | Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10818091 | PubMed |
| 20 | 30736810 | Diabetic encephalopathy: beneficial effects of supplementation with fatty acids ω3 and nordihydroguaiaretic acid in a spontaneous diabetes rat model. | Lipids Health Dis | 2019 | https://conductscience.org/library/papers/30736810 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42668333 | AMBMP Hydrochloride Reverses STZ-Induced Alzheimer-Type Dementia Associated with Wnt/β-catenin/TLR4 Signaling. | Neuromolecular Med | 2026 | https://conductscience.org/library/papers/42668333 | PubMed |
| 42654266 | Serum Biochemistry and Histopathological Profiles of Normoglycemic and Streptozotozin-Induced Hyperglycemic Rats Treated with Mace Water Extract from Myristica fragrans Houtt. | Nutrients | 2026 | https://conductscience.org/library/papers/42654266 | PubMed |
| 41998449 | Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer's disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41998449 | PubMed |
| 41975524 | Intracerebroventricular streptozotocin-induced animal model of Alzheimer's disease: revealing dose optimization, administration regimen, and molecular pathways. | Lab Anim Res | 2026 | https://conductscience.org/library/papers/41975524 | PubMed |
| 41227390 | Streptozotocin Causes Blood-Brain Barrier and Astrocytic Dysfunction In Vitro. | Cells | 2025 | https://conductscience.org/library/papers/41227390 | PubMed |
| 40801621 | Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer's Disease Are Associated with the Peripheral Suppression of Inflammation. | Cells | 2025 | https://conductscience.org/library/papers/40801621 | PubMed |
| 40571811 | Multidimensional Evaluation of the Streptozotocin-Induced Alzheimer's Model: Integrating Molecular, Histopathological, and Behavioral Correlates Over Time. | Neurochem Res | 2025 | https://conductscience.org/library/papers/40571811 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40201829
GET https://conductscience.org/api/papers/v1/40201829/references?page=2